Severe Late-Onset Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivor Patient: Importance of Post-Chemotherapy Surveillance.

ABSTRACT:

Background

Left ventricular (LV) dysfunction is a common and serious complication from cancer treatment. One of the common regimens that can cause cardiotoxicity is anthracycline, and anthracycline-induced cardiotoxicity may manifest after several years.

Case summary

A 32-year-old woman presented with heart failure syndrome late after chemotherapy administration for breast cancer therapy. Several months after chemotherapy completion, patient presented with overt LV dysfunction. The guideline-directed medical treatment was initiated. Patient demonstrated gradual recovery and progressive improvement of myocardial systolic performance with LV thrombus resolution after 5-month evaluation.

Discussion

The recognition of cancer therapy-related cardiac dysfunction (CTRCD) is

SUBMITTER: Hendiperdana R 

PROVIDER: S-EPMC12011159 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature